Heart Failure as a Risk Factor for Stroke
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Woo hyeun | - |
dc.contributor.author | Kim, Eung Ju | - |
dc.date.accessioned | 2021-07-30T05:10:18Z | - |
dc.date.available | 2021-07-30T05:10:18Z | - |
dc.date.created | 2021-05-14 | - |
dc.date.issued | 2018-01 | - |
dc.identifier.issn | 2287-6391 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/3406 | - |
dc.description.abstract | Heart failure (HF) is one of the major causes of death worldwide. Despite the high incidence of stroke in patients with HF, there has been a controversy as to whether HF itself is a risk factor for stroke. Recently, there is a great deal of evidence that HF itself increases the risk of stroke. In previous studies, the benefit of warfarin for stroke prevention in patients with HF was offset by the risk of bleeding. In the era of non-vitamin K antagonist oral anticoagulants with low bleeding profiles, we can expect a more effective stroke prevention in patients with HF by selective anticoagulation. The purpose of this review is to describe the relationship between stroke and HF, which could be an unconventional risk factor and a potential intervention target for stroke prevention. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | Korean Stroke Society | - |
dc.title | Heart Failure as a Risk Factor for Stroke | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Woo hyeun | - |
dc.identifier.doi | 10.5853/jos.2017.02810 | - |
dc.identifier.scopusid | 2-s2.0-85041725408 | - |
dc.identifier.wosid | 000423821500004 | - |
dc.identifier.bibliographicCitation | Journal of Stroke, v.20, no.1, pp.33 - 45 | - |
dc.relation.isPartOf | Journal of Stroke | - |
dc.citation.title | Journal of Stroke | - |
dc.citation.volume | 20 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 33 | - |
dc.citation.endPage | 45 | - |
dc.type.rims | ART | - |
dc.type.docType | 정기 학술지(Review) | - |
dc.identifier.kciid | ART002313444 | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Neurosciences & Neurology | - |
dc.relation.journalResearchArea | Cardiovascular System & Cardiology | - |
dc.relation.journalWebOfScienceCategory | Clinical Neurology | - |
dc.relation.journalWebOfScienceCategory | Peripheral Vascular Disease | - |
dc.subject.keywordPlus | WALL-MOTION ABNORMALITIES | - |
dc.subject.keywordPlus | CORONARY-ARTERY-DISEASE | - |
dc.subject.keywordPlus | VENTRICULAR SYSTOLIC DYSFUNCTION | - |
dc.subject.keywordPlus | ATRIAL-FIBRILLATION INSIGHTS | - |
dc.subject.keywordPlus | PRESERVED EJECTION FRACTION | - |
dc.subject.keywordPlus | SILENT CEREBRAL INFARCTION | - |
dc.subject.keywordPlus | VON-WILLEBRAND-FACTOR | - |
dc.subject.keywordPlus | 2016 ESC GUIDELINES | - |
dc.subject.keywordPlus | ISCHEMIC-STROKE | - |
dc.subject.keywordPlus | ANTITHROMBOTIC THERAPY | - |
dc.subject.keywordAuthor | Heart failure | - |
dc.subject.keywordAuthor | Stroke | - |
dc.subject.keywordAuthor | CHA(2)DS(2)-VASc score | - |
dc.identifier.url | https://www.j-stroke.org/journal/view.php?doi=10.5853/jos.2017.02810 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.